Barbara Pro, MD, an internationally recognized expert in lymphoma research and care, has been named Clinical Director of the Lymphoma Program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Pro is also Professor of Medicine in the Department of Medicine, Division of Hematology/Oncology, at Columbia University Vagelos College of Physicians and Surgeons. She assumed her roles on December 1, 2021.
Barbara Pro, MD
Widely recognized for her expertise in drug development for Hodgkin and non-Hodgkin lymphomas, Dr. Pro has played a major role in large international studies evaluating new therapies for patients with aggressive T-cell lymphomas.
